Managing neuropathic pain in bipolar disorder An overview of the clinical considerations for managing comorbid bipolar disorder and neuropathic pain.…
PJ view: Access to rare disease treatment should not be a rarity Policymakers and healthcare leaders must persevere with long overdue changes to improve access to treatments for rare diseases.…
Community pharmacy’s dispensing role ‘under threat’ A report published by the Company Chemists' Association has urged the government to safeguard dispensing as community pharmacy transitions toward more clinical services under the NHS ten-year plan.…
Managing the shift to prescribing at registration for pharmacists Prescribing from registration offers pharmacy and the wider healthcare sector a great opportunity, but this reform must be managed and supported properly.…
Pharmacy bodies express anger over exclusion from business rates relief Community pharmacy representatives disappointed that pharmacies were not included in government decision to cut business rates for pubs and live music venues.…
Type 1 diabetes mellitus and disordered eating An overview of the risks of type 1 diabetes mellitus and disordered eating — or ‘T1DE’, with management and communication considerations for healthcare professionals.…
Community pharmacy in focus: research insights on improving patient care The Royal Pharmaceutical Society’s former deputy chief scientist and Community Pharmacy England’s director of research reflect on recently published research studies in and through community pharmacy.…
Community pharmacies face ‘economic peril’, CPE warns government In an “uncompromising” letter, Community Pharmacy England said negotiations for the next pharmacy contract must close the funding gap for the sector.…
Pharmacy2U acquires Care Quality Pharmacy Care Quality Pharmacy offers prescription and NHS services to a variety of care home groups, extra care services and domiciliary care agencies.…
Everything you need to know about PrEP provision in community pharmacy Provision of pre-exposure prophylaxis is increasing across the UK and it has been shown to be highly effective. But why has there been so little progress on the long called-for expansion to provide the drugs via community pharmacy?…
